The CTLA4 +49 A/G (rs231775) polymorphism influences susceptibility to SLE in South Indian Tamils

Tissue Antigens

Volumn 83, Issue 6, 2014, Pages 418-421

  Devaraju, P ^a   Gulati, R ^a   Singh, B K ^a   Mithun, C B ^a   Negi, V S ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Autoantibodies; Cytotoxic T lymphocyte antigen 4; Systemic lupus erythematosus

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; AUTOANTIBODY; CTLA4 PROTEIN, HUMAN;

AFRICAN AMERICAN; ALLELE; ARTHRITIS; ARTICLE; ASIAN; CAUCASIAN; CENTRAL NERVOUS SYSTEM DISEASE; CHINESE; CONTROLLED STUDY; DISEASE ACTIVITY SCORE; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOBLOTTING; INDIA; INFLAMMATION; JAPANESE (PEOPLE); KIDNEY DISEASE; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; REAL TIME POLYMERASE CHAIN REACTION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TAMIL (PEOPLE); VASCULAR DISEASE; ADULT; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; CTLA-4 ANTIGEN; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84900518300     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12363     Document Type: Article

References (28)

1. Sestak AL, Nath SK, Sawalha AH, Harley JB. Current status of lupus genetics. Arthritis Res Ther 2007: 9: 210.
2. Ardoin SP, Pisetsky DS. Developments in the scientific understanding of lupus. Arthritis Res Ther 2008: 10: 218.
3. Oosterwegel M, Greenwald R, Mandelbrot D, Lorsbach R, Sharpe A. CTLA-4 and T cell activation. Curr Opin Immunol 1999: 11: 294-300.
4. Khattri R, Auger JA, Griffin MD, Sharpe AH, Bluestone JA. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2Responses. J Immunol 1999: 162: 5784-5791.
5. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun 2000: 1: 170-184.
6. Si X, Zhang X, Tang W, Luo Y. Association between the CTLA4 +49A/G polymorphism and Graves' disease: a meta-analysis. Exp Ther Med 2012: 4: 538-544.
7. Chen Z, Fei M, Fu D et al. Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis. Gene 2013: 10: 263-70.
8. Zhai JX, Zou LW, Zhang ZX, Fan WJ, Wang HY, Liu T, Ren Z, Dai RX, Ye D. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Mol Biol Rep 2013: 40: 5213-23.
9. Liu CP, Jiang JA, Wang T et al. CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China. Genet Mol Res 2013: 12: 1373-82.
10. Peng WJ, Pan HF, Tao JH et al. A meta-analysis of the association between cytokine gene polymorphisms and systemic sclerosis. Mod Rheumatol 2012: 22: 695-703.
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997: 40: 1725.
12. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992: 35: 630-40.
13. Miller SA, Dykes DD, Polesky HF. Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
14. Chambers CA, Krummel MF, Boitel B et al. The role of CTLA-4 in the regulation and initiation of T-cell response. Immunol Rev 1996: 153: 27.
15. Crispin JC, Kyttaris VC, Juang YT, Tsokos GC. How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype. Trends Immunol 2008: 29: 110-115.
16. Chang WW, Zhang L, Yao YS, Su H. Association between CTLA-4 exon-1 +49A/G polymorphism and systemic lupus erythematosus: an updated analysis. Mol Biol Rep 2012: 39: 9159-65.
17. Ahmed S, Ihara K, Kanemitsu S et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatol (Oxford) 2001: 40: 662-667.
18. Sugimoto K, Fujita S, Yanagida H et al. Clinical manifestations and analyses of the cytotoxic T-lymphocyte associated-4 gene in two Japanese families with systemic lupus erythematosus. Clin Exp Nephrol 2008: 12: 149-54.
19. Ulker M, Yazisiz V, Sallakci N et al. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients. Int J Immunogenet 2009: 36: 245-50.
20. Matsushita M, Tsuchiya N, Shiota M et al. Lack of a strong association of CTLA-4 exon 1 polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method. Tissue Antigens 1999: 54: 578-84.
21. Chua KH, Puah SM, Chew CH, Tan SY, Lian LH. Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia. Ann Hum Biol 2010: 37: 274-80.
22. Parks CG, Hudson LL, Cooper GS et al. CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States. Lupus 2004: 13: 784-91.
23. Xu AP, Yin PD, Su XY. Association of CTLA-4 promoter -1722 polymorphism with systemic lupus erythematosus in Chinese. Di Yi Jun Yi Da Xue Xue Bao 2004: 24: 1107-12.
24. Barton A, Jury F, Eyre S et al. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis Rheum 2004: 50: 748-52.
25. Nistico L, Buzzetti R, Pritchard LE et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 1996: 5: 1075-1080.
26. Liu MF, Wang CR, Chen PC, Fung LL. Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus. Scand J Immunol 2003: 57: 568-72.
27. Scalapino KJ, Daikh ID. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Reviews 2008: 223: 143-155.
28. Barreto M, Ferreira RC, Lourenço L, Moraes-Fontes MF, Santos E et al. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants. BMC Immunol 2009: 10: 5.